Long-term outcomes from upgrade to cardiac resynchronisation therapy in ischaemic versus non-ischaemic heart disease

G Yuecel, K Stoesslein, L Gaasch, A Kodeih… - Acta …, 2024 - Taylor & Francis
Background Cardiac resynchronisation therapy (CRT) can be necessary in patients with
chronic heart failure, who have already been provided with transvenous cardiac implantable …

Long-term outcomes from upgrade to cardiac resynchronisation therapy in ischaemic versus non-ischaemic heart disease

G Yuecel, K Stoesslein, L Gaasch, A Kodeih… - Acta …, 2024 - ingentaconnect.com
Background Cardiac resynchronisation therapy (CRT) can be necessary in patients with
chronic heart failure, who have already been provided with transvenous cardiac implantable …

Long-term outcomes from upgrade to cardiac resynchronisation therapy in ischaemic versus non-ischaemic heart disease

G Yuecel, K Stoesslein, L Gaasch… - Acta …, 2024 - pubmed.ncbi.nlm.nih.gov
Background Cardiac resynchronisation therapy (CRT) can be necessary in patients with
chronic heart failure, who have already been provided with transvenous cardiac implantable …

Long-term outcomes from upgrade to cardiac resynchronisation therapy in ischaemic versus non-ischaemic heart disease.

G Yuecel, K Stoesslein, L Gaasch, A Kodeih… - Acta …, 2023 - europepmc.org
Background Cardiac resynchronisation therapy (CRT) can be necessary in patients with
chronic heart failure, who have already been provided with transvenous cardiac implantable …